The National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) and AstraZeneca are collaborating to seek proposals for improving care processes for patients with unresectable stage III and stage IV non-small cell lung cancer...
31-May-2019 8:30 AM EDT Add to Favorites
New NCCN Guidelines for Children with Cancer Meet Growing Needs of Pediatric Oncology Community Worldwide
National Comprehensive Cancer Network (NCCN) debuts NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Acute Lymphoblastic Leukemia (ALL)—comprehensive, up-to-date, evidence-based, consensus-driven guidelines for...
29-May-2019 12:05 PM EDT Add to Favorites
Adding Bevacizumab to Lung Cancer Treatment Results in Modest Overall Survival Benefits, According to Study in JNCCN from Abramson Cancer Center
Researchers from University of Pennsylvania find adding bevacizumab to carboplatin-pemetrexed was effective in treating non-squamous non-small cell lung cancer, in new study published in JNCCN—Journal of the National Comprehensive Cancer Network.
22-May-2019 4:40 PM EDT Add to Favorites
NCCN Advances Cancer Research and Oncology Career Development with Young Investigator Awards, Poster Presentations, and Fellows Program
The National Comprehensive Cancer Network announces 2019 Young Investigator Award recipients, and provides information about abstract poster presentations and fellows program from NCCN 2019 Annual Conference.
8-May-2019 8:30 AM EDT Add to Favorites
National Comprehensive Cancer Network Working with Health Officials in Bolivia to Improve Cancer Care
National Comprehensive Cancer Network to adapt NCCN Guidelines® for Breast, Cervical, and Rectal Cancer to better meet cancer burden and resource levels in Bolivia.
24-Apr-2019 8:30 AM EDT Add to Favorites
New Research in JNCCN Touts Ice Chips as a Simple, Inexpensive Way to Reduce a Common Chemotherapy Side Effect
Researchers from Abramson Cancer Center at the University of Pennsylvania find patients who kept ice chips in their mouths during infusion with oxaliplatin reported less trouble eating and drinking than patients who were not exposed to this...
15-Apr-2019 11:05 AM EDT Add to Favorites
CAR T as Plan B: A Case Study on the Personal and Systemic Difficulties from Immunotherapy and Other Innovative Cancer Treatments
CAR T-Cell therapy, immunotherapy, and other innovative cancer treatments were the focus of a patient-centered keynote and roundtable discussion at the NCCN 2019 Annual Conference (#NCCNac19)
15-Apr-2019 8:45 AM EDT Add to Favorites
ASCO, ASH, and NCCN receive letter clarifying CDC Guideline for Prescribing Opioids for Chronic Pain not meant to limit access to appropriate pain management for individuals with cancer, sickle cell disease
9-Apr-2019 10:00 AM EDT Add to Favorites
see all news